Infographic_fon-2021-1006.pdf (2.18 MB)
Download file

Infographic – Summary of the CaboPoint study

Download (2.18 MB)
figure
posted on 20.12.2021, 14:30 authored by Laurence Albiges, Manuela Schmidinger, Naila Taguieva-Pioger, David Perol, Viktor Grünwald, Eric Guemas
CaboPoint: a Phase II study of cabozantinib as second-line treatment in patients with metastatic renal cell carcinoma

Funding

Ipsen

History